Viatris

VTRS | NASDAQ | 28 Followers

$8.50

0.24%

$0.02

Overview Metrics Financials

Fair Price

$10.16

Undervalued by 84.6%

To display the fair price of a share, you need to be a member of Bulios Black.

Company Quality

Dividends

Earnings

My Notes

You haven't added any notes for this stock yet. Use this space to record your insights or strategies.

Profile

Viatris Inc. is a pharmaceutical company formed through the merger of two significant pharmaceutical firms. The company specializes in research, development, and manufacturing of prescription medicines, generic drugs, and biosimilars. Viatris offers a broad range of medications for various diseases, from common ailments to serious health conditions. The company is active in the global pharmaceutical market, providing treatment for millions of patients worldwide. Viatris focuses on improving accessibility and affordability of medicines and providing quality alternative treatment options. The company also invests in research for new drugs and treatment approaches to better address patients' healthcare needs. Viatris Inc. (VTRS) shares are an interesting choice for investors who follow the pharmaceutical sector and seek investment opportunities in a global pharmaceutical company with an extensive portfolio of medicines and research activities.

Viatris

Fair Price

Company Quality

Dividends

Earnings

My Notes

Profile

Key Metrics TTM

Performance

Earnings Waterfall

Debt level and coverage

Earnings

Feed

Log in to Bulios

Create Bulios profile

Why Bulios?